These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 2220012

  • 1. [Effect of cibenzoline on atrial vulnerability and value of electrophysiological methods in the treatment of paroxysmal atrial fibrillation].
    Kühlkamp V, Ickrath O, Seipel L.
    Z Kardiol; 1990 Aug; 79(8):541-6. PubMed ID: 2220012
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
    Kühlkamp V, Meerhof J, Schmidt F, Mayer F, Ickrath O, Haasis R, Seipel L.
    Am J Cardiol; 1990 Mar 01; 65(9):628-32. PubMed ID: 2309633
    [Abstract] [Full Text] [Related]

  • 3. [Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].
    Inoue D, Ishibashi K, Sakai R, Inoue M, Omori I, Asayama J, Nakagawa M.
    Kokyu To Junkan; 1992 Dec 01; 40(12):1203-8. PubMed ID: 1480832
    [Abstract] [Full Text] [Related]

  • 4. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z, Van Der Voort PH, Blaauw Y, Duytschaever M, Allessie MA.
    J Cardiovasc Electrophysiol; 2004 May 01; 15(5):572-80. PubMed ID: 15149428
    [Abstract] [Full Text] [Related]

  • 5. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 01; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 6. [Efficacy of cibenzoline in the termination and long-term prevention of paroxysmal atrial fibrillation: analysis based on the time of onset].
    Komatsu T, Nakamura S, Kimura M, Owada S, Saito E, Kobayashi T, Okumura K.
    J Cardiol; 2001 Feb 01; 37(2):75-82. PubMed ID: 11255698
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A, Attuel P, Manot S, Fiorello P, Halimi F, Leclercq JF.
    Europace; 2000 Oct 01; 2(4):304-11. PubMed ID: 11194597
    [Abstract] [Full Text] [Related]

  • 9. Clinical assessment of antiarrhythmic agents for paroxysmal atrial fibrillation guided by modification of electrophysiologic arrhythmogenicity.
    Sasano T, Okishige K, Azegami K, Isobe M.
    J Cardiovasc Electrophysiol; 2004 Nov 01; 15(11):1250-7. PubMed ID: 15574173
    [Abstract] [Full Text] [Related]

  • 10. [Effect of a new class I anti-arrhythmia agent cibenzoline in patients with therapy refractory, sustained ventricular tachycardias].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Sep 01; 77(9):595-9. PubMed ID: 3195178
    [Abstract] [Full Text] [Related]

  • 11. Serial cardioversion by class IC Drugs during 4 months of persistent atrial fibrillation in the goat.
    Eijsbouts S, Ausma J, Blaauw Y, Schotten U, Duytschaever M, Allessie MA.
    J Cardiovasc Electrophysiol; 2006 Jun 01; 17(6):648-54. PubMed ID: 16836716
    [Abstract] [Full Text] [Related]

  • 12. [Efficacy of cibenzoline in a case of atrial fibrillation due to cardiac thyrotoxicosis].
    Niakara A, Nébié LV, Samadoulougou AK, Kaboré NJ, Ouandaogo BJ, Drabo YJ.
    Ann Cardiol Angeiol (Paris); 1999 Feb 01; 48(2):113-7; discussion 118. PubMed ID: 12555335
    [Abstract] [Full Text] [Related]

  • 13. [Biatrial pacing--new possibility in the non-pharmacologic treatment of drug-resistant paroxysmal atrial fibrillation].
    Merkely B, Vágó H, Gellér L, Zima E, Tomcsányi J, Bodor E.
    Orv Hetil; 2001 Feb 04; 142(5):235-40. PubMed ID: 11243011
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study of the efficacy and tolerability of 2 modalities of intravenous cibenzoline administration in the reduction of recent spontaneous atrial arrhythmia].
    Hermida JS, Mabo P, Rouesnel P, Scheck F, Canler A, Barthélémy M, Wanszelbaum H.
    Ann Cardiol Angeiol (Paris); 1995 Jan 04; 44(1):49-55. PubMed ID: 7702357
    [Abstract] [Full Text] [Related]

  • 15. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A, Matteucci C, Patrissi T, Accogli S, Di Lorenzo M, Sasdelli M, Ciolli A, Lo Sardo G, Palamara A.
    G Ital Cardiol; 1998 Dec 04; 28(12):1391-9. PubMed ID: 9887393
    [Abstract] [Full Text] [Related]

  • 16. [Anti-arrhythmia and pro-arrhythmia effects of oral cibenzoline therapy in sustained ventricular tachycardia].
    Hoffmann E, Bach P, Haberl R, Mattke S, Steinbeck G.
    Z Kardiol; 1992 Jul 04; 81(7):378-84. PubMed ID: 1509795
    [Abstract] [Full Text] [Related]

  • 17. [Atrial electrophysiological study of unexplained ischemic cerebrovascular disorders].
    Reeb T, de Chillou C, Sadoul N, Lacour JC, Ducrocq X, Debouverie M, Weber M, Aliot E.
    Arch Mal Coeur Vaiss; 1995 Dec 04; 88(12):1855-61. PubMed ID: 8729366
    [Abstract] [Full Text] [Related]

  • 18. [Value of the study of latent atrial vulnerability in unexplained ischemic cerebrovascular accident of young subjects].
    Somody E, Albucher JF, Delay M, Chollet F, Bonnet JP, Fourcade J, Guiraud-Chaumeil B, Puel J.
    Arch Mal Coeur Vaiss; 1996 Nov 04; 89(11):1365-73. PubMed ID: 9092394
    [Abstract] [Full Text] [Related]

  • 19. [Cibenzoline: electrophysiologic effects of a new class I anti-arrhythmia agents in supraventricular tachycardia].
    Pfitzner P, Manz M, Schütz R, Lüderitz B.
    Z Kardiol; 1989 Oct 04; 78(10):654-60. PubMed ID: 2686252
    [Abstract] [Full Text] [Related]

  • 20. Hybrid therapy of atrial fibrillation.
    Santini M, Pignalberi C, Ricci R, Calò L.
    Ital Heart J; 2002 Oct 04; 3(10):571-8. PubMed ID: 12478814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.